
About Ador Multiproducts
Ador Multiproducts is a publicly listed company based in Mumbai (India) founded in 1948. Personal care products are manufactured and supplied by Ador Multiproducts. The company has 7 employees. Its Indian entity Thrive Future Habitats Limited reported revenue of βΉ2.33 Cr. Ador Multiproducts offers products and services including Sublime Life, Cocomo, Anatomicals, Booth & Berkeley, and Santic. Its focus areas include Retail, Contract Manufacturers, FMCG and Cosmetics. Its competitors include Primacy Industries, Influx Healthtech and Stella Indusstries; 1 of its 3 listed competitors has raised funding.
Company details
Ador Multiproducts was founded in 1948 and operates in the personal care sector. Skin care items, hygiene products such as hand sanitizers, and both alcohol-based and herbal options are produced and supplied. Contract manufacturing services are provided from facilities located in Bengaluru and Pondicherry, with headquarters in Mumbai, India.
- Headquarters Mumbai, India
- Employees 7
- Stage Public
- SectorsIndustrial Goods & Manufacturing
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website adormultiproducts.com
- Social LinkedIn
- Legal Name Ador Multiproducts Ltd.
- Market Cap₹91.69 Cr
THRIVE · BSE
- Share Price₹84.90
+4.81% today
- Revenue₹1.23 Cr
FY 2025-26 · -43.6% YoY
- EBITDA−₹1.77 Cr
Margin -143.9%
- Net Profit−₹2.06 Cr
FY 2025-26 · -398.6% YoY
- Debt / Equity0.02
Interest cover -7.6x
- Employee Count7
Associated legal entities of Ador Multiproducts
Ador Multiproducts operates through Thrive Future Habitats Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Thrive Future Habitats Limited Listed CIN L85110MH1948PLC310253 | Active | 23 Jul 1948 | Mumbai, Maharashtra | ₹2.3 Cr | 10 | 5 | View details |
Products & Services of Ador Multiproducts
Ador Multiproducts offers a comprehensive portfolio of products and services, including Sublime Life, Cocomo, Anatomicals, Booth & Berkeley, and Santic.
Online curation of clean and safe beauty brands.
Hand-crafted cleansers and lotions for children.
Paraben-free toiletries manufactured in India.
Men's grooming products from head to toe.
Hygiene products for home and community use.
Funding Insights of Ador Multiproducts
- Total Rounds 1
All 1 funding rounds of Ador Multiproducts with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2020 | Post-IPO | β | β | β |
Board of directors of Thrive Future Habitats Limited (Ador Multiproducts)
Thrive Future Habitats Limited is the primary company behind Ador Multiproducts. The board of Thrive Future Habitats Limited currently have 4 directors; the longest-serving is Sandeep Ahuja, appointed in 2025. 20 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sandeep Ahuja DIN 00043118 | Director | 20 Mar 2025 | 1 yr 7 mo | Thrive Future Habitats Limited |
| Arvinder Singh Pasricha DIN 00032420 | Director | 27 May 2025 | 1 yr 4 mo | Thrive Future Habitats Limited |
| Vinay Kumar Singh DIN 06497700 | Managing Director | 27 May 2025 | 1 yr 4 mo | Thrive Future Habitats Limited |
| Praveen Kumari Singh DIN 11096754 | Director | 27 May 2025 | 1 yr 4 mo | Thrive Future Habitats Limited |
People of Ador Multiproducts
3 people are tracked at Ador Multiproducts (3 in leadership); the tracked headcount is 7.
| Name | Role | Group |
|---|---|---|
Aruna Advani | Chairman | Leadership |
Ninotchka Malkani Nagpal | Chairman | Leadership |
Ravin Mirchandani | Executive Chairman | Leadership |
Complete people profiles for Ador Multiproducts
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Ador Multiproducts
Ador Multiproducts is a publicly listed company on the BSE with ticker symbol ADORMUL in India, operating in the Consumer non-durables sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date26 Aug 2002
- Listed onBSE: 523120
- Listed entityAdor Multiproducts Ltd.
- Exchange sectorConsumer non-durables
- ISININE628D01014
- Share price₹135.60 (+4.99% on the day) · 2025-12-10
- Market capitalisation₹123 Cr
- EPS (diluted, trailing year)₹-7.42
- Volume (last session)6,294
- Analyst consensusNeutral
Financials of Ador Multiproducts
Exchange-reported figures of Thrive Future Habitats Limited, the listed company behind Ador Multiproducts (BSE: THRIVE).
Financial Highlights
FY 2025-26 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1.23 | 2.18 | 6.73 | 12.17 | 13.44 | 19.34 | 9.87 |
| Revenue growth | -43.6% | -67.6% | -44.7% | -9.5% | -30.5% | +96.0% | - |
| EBITDA | (1.77) | (3.29) | (7.93) | (8.52) | (6.36) | (1.08) | (3.10) |
| EBITDA margin | -143.9% | -150.9% | -117.8% | -70.0% | -47.3% | -5.6% | -31.4% |
| Profit before tax | (1.03) | (3.20) | (3.32) | (9.05) | (6.80) | 2.54 | (3.20) |
| Net profit | (2.06) | 0.69 | (4.07) | (9.11) | (6.93) | (1.42) | (2.86) |
| Net profit margin | -167.5% | +31.7% | -60.5% | -74.9% | -51.6% | -7.3% | -29.0% |
| EPS (βΉ) | (0.90) | (4.25) | (9.79) | (19.49) | (14.83) | 3.20 | (7.20) |
| Balance sheet | |||||||
| Total assets | 46.05 | 2.84 | 5.29 | 9.13 | 17.72 | 13.86 | 10.48 |
| Net worth | 52.72 | 9.06 | 11.03 | 15.22 | 20.74 | 13.46 | 7.83 |
| Total debt | 0.28 | 0.69 | 0.00 | 0.06 | 0.09 | 2.58 | 4.23 |
| Cash & bank | 22.17 | 0.00 | 0.07 | 0.06 | 4.41 | 1.02 | 1.20 |
| Net working capital | 22.97 | 0.49 | 1.52 | (0.26) | 7.71 | 4.60 | 2.77 |
| Cash flow | |||||||
| Cash from operations | (3.36) | 0.17 | 0.87 | (6.76) | (8.85) | (7.06) | (3.68) |
| Cash from investing | (18.31) | 0.18 | 0.23 | 0.19 | (0.90) | 4.19 | 3.18 |
| Cash from financing | 43.84 | (0.42) | (0.03) | 0.36 | 12.91 | 2.69 | 1.09 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.35 | 0.47 | 0.08 | 0.37 | 0.30 | 0.66 | 0.63 | 0.22 |
| Revenue growth (YoY) | +16.7% | -28.8% | -87.3% | +68.2% | -55.2% | - | - | - |
| Other income | 0.60 | 0.30 | 0.75 | 0.01 | 0.01 | 0.10 | 0.01 | 0.23 |
| EBITDA | (1.33) | (1.00) | (0.19) | (0.38) | (0.24) | (2.92) | (0.04) | (0.15) |
| EBITDA margin | -380.0% | -212.8% | -237.5% | -102.7% | -80.0% | -449.2% | -6.3% | -68.2% |
| Depreciation | 0.11 | 0.08 | 0.04 | 0.05 | 0.04 | 0.13 | 0.13 | 0.20 |
| Interest | 0.09 | 0.09 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 |
| Profit before tax | (0.93) | (0.87) | 0.51 | (0.43) | (0.28) | (2.97) | (0.18) | (0.15) |
| Tax | (0.01) | (0.18) | 0.17 | 0.00 | 0.00 | (0.02) | 0.00 | 0.00 |
| Net profit | (0.92) | (0.69) | 0.34 | (0.43) | (0.28) | (2.95) | (0.18) | (0.15) |
| EPS (βΉ) | (0.45) | (0.40) | 0.36 | (0.44) | (0.30) | (6.32) | (0.39) | (0.31) |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1.22 | 2.18 | 5.15 | 5.89 | 7.21 | 17.57 | 8.26 |
| Revenue growth | -44.0% | -57.7% | -12.6% | -18.3% | -59.0% | +112.7% | - |
| EBITDA | (1.71) | (0.48) | (10.24) | (1.60) | (0.62) | 1.95 | (0.41) |
| EBITDA margin | -140.2% | -22.0% | -198.8% | -27.2% | -8.6% | +11.1% | -5.0% |
| Profit before tax | (0.99) | (0.68) | (10.51) | (1.98) | (0.64) | 6.05 | (0.43) |
| Net profit | (0.98) | (0.60) | (0.74) | (1.97) | (0.77) | 1.73 | (0.08) |
| Net profit margin | -80.3% | -27.5% | -14.4% | -33.5% | -10.7% | +9.9% | -1.0% |
| EPS (βΉ) | (0.86) | (1.39) | (22.42) | (4.21) | (1.64) | 10.72 | (0.20) |
| Balance sheet | |||||||
| Total assets | 46.08 | 2.82 | 3.75 | 14.38 | 15.47 | 16.11 | 9.44 |
| Net worth | 45.76 | 2.06 | 2.70 | 13.17 | 15.14 | 15.89 | 7.75 |
| Total debt | 0.28 | 0.69 | 1.02 | 1.12 | 0.23 | 0.00 | 1.50 |
| Cash & bank | 22.17 | 0.00 | 0.02 | 0.04 | 0.19 | 0.80 | 0.87 |
| Net working capital | 22.99 | 0.47 | 1.26 | 1.89 | 2.69 | 4.55 | 2.95 |
| Cash flow | |||||||
| Cash from operations | (3.39) | 0.22 | (9.67) | (0.98) | 0.18 | (4.13) | (0.94) |
| Cash from investing | (18.29) | 0.18 | 9.93 | 0.02 | (0.89) | 0.96 | 0.46 |
| Cash from financing | 43.84 | (0.42) | (0.18) | (0.07) | (0.13) | 3.09 | 0.75 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.35 | 0.47 | 0.08 | 0.37 | 0.30 | 0.66 | 0.63 | 0.22 |
| Revenue growth (YoY) | +16.7% | -28.8% | -87.3% | +68.2% | -55.2% | - | - | - |
| Other income | 0.60 | 0.28 | 0.75 | 0.03 | 0.01 | 0.09 | 0.01 | 0.05 |
| Total expenses | 1.65 | 1.41 | 0.27 | 0.74 | 0.54 | 0.80 | 0.67 | 0.36 |
| EBITDA | (1.30) | (0.94) | (0.19) | (0.37) | (0.24) | (0.14) | (0.04) | (0.14) |
| EBITDA margin | -371.4% | -200.0% | -237.5% | -100.0% | -80.0% | -21.5% | -6.3% | -63.6% |
| Depreciation | 0.11 | 0.08 | 0.04 | 0.04 | 0.04 | 0.06 | 0.06 | 0.06 |
| Interest | 0.09 | 0.09 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 |
| Profit before tax | (0.90) | (0.83) | 0.51 | (0.39) | (0.28) | (0.13) | (0.11) | (0.18) |
| Tax | (0.01) | (0.18) | 0.17 | 0.00 | 0.00 | 0.19 | 0.00 | 0.00 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.35 | 0.47 | 0.08 | 0.37 | 0.30 | 0.66 | 0.63 | 0.22 |
| Revenue growth (YoY) | +16.7% | -28.8% | -87.3% | +68.2% | -55.2% | - | - | - |
| Other income | 0.60 | 0.30 | 0.75 | 0.01 | 0.01 | 0.10 | 0.01 | 0.23 |
| EBITDA | (1.33) | (1.00) | (0.19) | (0.38) | (0.24) | (2.92) | (0.04) | (0.15) |
| EBITDA margin | -380.0% | -212.8% | -237.5% | -102.7% | -80.0% | -449.2% | -6.3% | -68.2% |
| Depreciation | 0.11 | 0.08 | 0.04 | 0.05 | 0.04 | 0.13 | 0.13 | 0.20 |
| Interest | 0.09 | 0.09 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 |
| Profit before tax | (0.93) | (0.87) | 0.51 | (0.43) | (0.28) | (2.97) | (0.18) | (0.15) |
| Tax | (0.01) | (0.18) | 0.17 | 0.00 | 0.00 | (0.02) | 0.00 | 0.00 |
| Net profit | (0.92) | (0.69) | 0.34 | (0.43) | (0.28) | (2.95) | (0.18) | (0.15) |
| EPS (βΉ) | (0.45) | (0.40) | 0.36 | (0.44) | (0.30) | (6.32) | (0.39) | (0.31) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.23 | 2.18 | 6.73 | 12.17 | 13.44 | 19.34 | 9.87 |
| Revenue growth | -43.6% | -67.6% | -44.7% | -9.5% | -30.5% | +96.0% | - |
| Other income | 1.10 | 0.79 | 5.44 | 0.31 | 0.30 | 4.27 | 0.54 |
| Total expenses | 3.00 | 5.47 | 14.66 | 20.69 | 19.80 | 20.42 | 12.97 |
| Employee cost | 0.91 | 0.45 | 1.07 | 3.10 | 2.75 | 2.39 | 2.13 |
| EBITDA | (1.77) | (3.29) | (7.93) | (8.52) | (6.36) | (1.08) | (3.10) |
| EBITDA margin | -143.9% | -150.9% | -117.8% | -70.0% | -47.3% | -5.6% | -31.4% |
| Depreciation | 0.21 | 0.60 | 0.53 | 0.69 | 0.43 | 0.36 | 0.26 |
| Interest | 0.15 | 0.10 | 0.30 | 0.15 | 0.31 | 0.29 | 0.38 |
| Profit before tax | (1.03) | (3.20) | (3.32) | (9.05) | (6.80) | 2.54 | (3.20) |
| Tax | (0.01) | (0.03) | 0.71 | 0.06 | 0.13 | 1.04 | (0.34) |
| Net profit | (2.06) | 0.69 | (4.07) | (9.11) | (6.93) | (1.42) | (2.86) |
| Net profit margin | -167.5% | +31.7% | -60.5% | -74.9% | -51.6% | -7.3% | -29.0% |
| EPS (βΉ) | (0.90) | (4.25) | (9.79) | (19.49) | (14.83) | 3.20 | (7.20) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 11.32 | 4.67 | 4.67 | 4.67 | 4.67 | 4.67 | 3.96 |
| Reserves & surplus | 34.09 | 4.39 | 6.36 | 10.55 | 16.07 | 8.79 | 3.87 |
| Shareholders' funds (net worth) | 52.72 | 9.06 | 11.03 | 15.22 | 20.74 | 13.46 | 7.83 |
| Minority interest | (7.00) | (6.97) | (5.78) | (6.46) | (3.37) | (2.52) | (1.88) |
| Secured loans | 0.00 | 0.69 | 0.00 | 0.00 | 0.00 | 2.58 | 3.74 |
| Unsecured loans | 0.28 | 0.00 | 0.00 | 0.06 | 0.09 | 0.00 | 0.49 |
| Total debt | 0.28 | 0.69 | 0.00 | 0.06 | 0.09 | 2.58 | 4.23 |
| Total liabilities | 46.05 | 2.84 | 5.29 | 9.13 | 17.72 | 13.86 | 10.48 |
| Assets | |||||||
| Gross block | 5.30 | 4.28 | 6.37 | 10.98 | 10.88 | 9.42 | 9.72 |
| Net block | 2.60 | 1.79 | 3.33 | 8.16 | 8.74 | 7.68 | 6.77 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 19.16 | 0.54 | 0.61 | 0.62 | 0.61 | 0.86 | 0.13 |
| Inventories | 0.85 | 1.01 | 1.77 | 5.30 | 5.45 | 4.74 | 3.94 |
| Sundry debtors | 0.04 | 0.13 | 0.19 | 1.32 | 1.61 | 1.88 | 2.48 |
| Cash & bank balances | 22.17 | 0.00 | 0.07 | 0.06 | 4.41 | 1.02 | 1.20 |
| Loans & advances | 0.40 | 0.02 | 2.14 | 2.84 | 2.34 | 2.03 | 1.57 |
| Total current assets | 23.46 | 1.16 | 4.17 | 9.52 | 13.81 | 9.67 | 9.19 |
| Total current liabilities | 0.49 | 0.67 | 2.65 | 9.78 | 6.10 | 5.07 | 6.42 |
| Net working capital | 22.97 | 0.49 | 1.52 | (0.26) | 7.71 | 4.60 | 2.77 |
| Total assets | 46.05 | 2.84 | 5.29 | 9.13 | 17.72 | 13.86 | 10.48 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.00 | 0.07 | (2.02) | 4.18 | 1.02 | 1.20 | 0.61 |
| Net cash from operating activities | (3.36) | 0.17 | 0.87 | (6.76) | (8.85) | (7.06) | (3.68) |
| Net cash from investing activities | (18.31) | 0.18 | 0.23 | 0.19 | (0.90) | 4.19 | 3.18 |
| Net cash from financing activities | 43.84 | (0.42) | (0.03) | 0.36 | 12.91 | 2.69 | 1.09 |
| Net change in cash | 22.16 | (0.07) | 1.08 | (6.20) | 3.16 | (0.18) | 0.59 |
| Closing cash | 22.17 | 0.00 | 0.07 | 0.06 | 4.41 | 1.02 | 1.20 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -43.6% | -67.6% | -44.7% | -9.5% | -30.5% | +96.0% | - |
| EBITDA growth | +46.2% | +58.5% | +6.9% | -34.0% | -488.9% | +65.2% | - |
| PBT growth | +67.8% | +3.6% | +63.3% | -33.1% | - | +9998.0% | -133.6% |
| Net income growth | -398.6% | +117.0% | +55.3% | -31.5% | -388.0% | +50.4% | - |
| Revenue CAGR (3Y) | -53.4% | -45.5% | -29.7% | +7.2% | +22.7% | +43.3% | +13.8% |
| EBITDA CAGR (3Y) | -40.8% | -19.7% | +94.4% | +40.1% | +70.6% | +11.0% | +32.9% |
| Profitability & leverage | |||||||
| Net income margin | -82.9% | -145.4% | -59.9% | -74.9% | -51.6% | +7.8% | -29.0% |
| Return on capital employed | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -7.9% | 0.0% |
| Return on net worth | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -13.3% | 0.0% |
| Debt / equity | 0.02 | 0.03 | 0.00 | 0.00 | 0.08 | 0.32 | 0.36 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | -7.58 | -2.57 | -3.55 | -1.63 | -4.57 | -20.14 | -11.31 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.26 | 0.41 | 0.78 | 1.11 | 1.32 | 2.02 | 1.34 |
| Inventory turnover | 1.32 | 1.57 | 1.90 | 2.26 | 2.64 | 4.46 | 3.84 |
| Debtors turnover | 14.47 | 13.63 | 8.91 | 8.31 | 7.70 | 8.87 | 5.21 |
| EPS (βΉ) | (0.90) | (4.25) | (9.79) | (19.49) | (14.83) | 3.20 | (7.20) |
| Dividend per share (βΉ) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (βΉ) | 40.12 | 19.39 | 23.62 | 32.57 | 44.38 | 28.81 | 19.76 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.35 | 0.47 | 0.08 | 0.37 | 0.30 | 0.66 | 0.63 | 0.22 |
| Revenue growth (YoY) | +16.7% | -28.8% | -87.3% | +68.2% | -55.2% | - | - | - |
| Other income | 0.60 | 0.28 | 0.75 | 0.03 | 0.01 | 0.09 | 0.01 | 0.05 |
| Total expenses | 1.65 | 1.41 | 0.27 | 0.74 | 0.54 | 0.80 | 0.67 | 0.36 |
| EBITDA | (1.30) | (0.94) | (0.19) | (0.37) | (0.24) | (0.14) | (0.04) | (0.14) |
| EBITDA margin | -371.4% | -200.0% | -237.5% | -100.0% | -80.0% | -21.5% | -6.3% | -63.6% |
| Depreciation | 0.11 | 0.08 | 0.04 | 0.04 | 0.04 | 0.06 | 0.06 | 0.06 |
| Interest | 0.09 | 0.09 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.03 |
| Profit before tax | (0.90) | (0.83) | 0.51 | (0.39) | (0.28) | (0.13) | (0.11) | (0.18) |
| Tax | (0.01) | (0.18) | 0.17 | 0.00 | 0.00 | 0.19 | 0.00 | 0.00 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1.22 | 2.18 | 5.15 | 5.89 | 7.21 | 17.57 | 8.26 |
| Revenue growth | -44.0% | -57.7% | -12.6% | -18.3% | -59.0% | +112.7% | - |
| Other income | 1.08 | 0.16 | 0.16 | 0.03 | 0.30 | 4.44 | 0.31 |
| Total expenses | 2.93 | 2.66 | 15.39 | 7.49 | 7.83 | 15.62 | 8.67 |
| Employee cost | 0.91 | 0.45 | 0.45 | 0.91 | 0.96 | 1.36 | 1.08 |
| EBITDA | (1.71) | (0.48) | (10.24) | (1.60) | (0.62) | 1.95 | (0.41) |
| EBITDA margin | -140.2% | -22.0% | -198.8% | -27.2% | -8.6% | +11.1% | -5.0% |
| Depreciation | 0.21 | 0.26 | 0.29 | 0.30 | 0.29 | 0.28 | 0.20 |
| Interest | 0.15 | 0.10 | 0.14 | 0.11 | 0.03 | 0.06 | 0.13 |
| Profit before tax | (0.99) | (0.68) | (10.51) | (1.98) | (0.64) | 6.05 | (0.43) |
| Tax | (0.01) | (0.03) | (0.03) | (0.01) | 0.13 | 1.04 | (0.35) |
| Net profit | (0.98) | (0.60) | (0.74) | (1.97) | (0.77) | 1.73 | (0.08) |
| Net profit margin | -80.3% | -27.5% | -14.4% | -33.5% | -10.7% | +9.9% | -1.0% |
| EPS (βΉ) | (0.86) | (1.39) | (22.42) | (4.21) | (1.64) | 10.72 | (0.20) |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 11.32 | 4.67 | 4.67 | 4.67 | 4.67 | 4.67 | 3.96 |
| Reserves & surplus | 27.13 | (2.61) | (1.97) | 8.50 | 10.47 | 11.22 | 3.79 |
| Shareholders' funds (net worth) | 45.76 | 2.06 | 2.70 | 13.17 | 15.14 | 15.89 | 7.75 |
| Secured loans | 0.00 | 0.69 | 1.02 | 1.12 | 0.23 | 0.00 | 1.50 |
| Unsecured loans | 0.28 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total debt | 0.28 | 0.69 | 1.02 | 1.12 | 0.23 | 0.00 | 1.50 |
| Total liabilities | 46.08 | 2.82 | 3.75 | 14.38 | 15.47 | 16.11 | 9.44 |
| Assets | |||||||
| Gross block | 5.30 | 4.27 | 4.27 | 4.27 | 4.26 | 4.22 | 5.17 |
| Net block | 2.60 | 1.78 | 2.04 | 2.33 | 2.62 | 2.83 | 2.49 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 19.16 | 0.54 | 0.61 | 10.37 | 10.37 | 8.87 | 4.11 |
| Inventories | 0.85 | 1.01 | 1.77 | 2.50 | 2.82 | 3.06 | 3.20 |
| Sundry debtors | 0.04 | 0.13 | 0.19 | 1.07 | 1.14 | 1.48 | 2.13 |
| Cash & bank balances | 22.17 | 0.00 | 0.02 | 0.04 | 0.19 | 0.80 | 0.87 |
| Loans & advances | 0.42 | 0.00 | 0.20 | 0.29 | 0.41 | 2.55 | 1.76 |
| Total current assets | 23.48 | 1.14 | 2.18 | 3.90 | 4.56 | 7.89 | 7.96 |
| Total current liabilities | 0.49 | 0.67 | 0.92 | 2.01 | 1.87 | 3.34 | 5.01 |
| Net working capital | 22.99 | 0.47 | 1.26 | 1.89 | 2.69 | 4.55 | 2.95 |
| Total assets | 46.08 | 2.82 | 3.75 | 14.38 | 15.47 | 16.11 | 9.44 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 0.00 | 0.02 | (1.08) | (0.05) | 0.80 | 0.87 | 0.61 |
| Net cash from operating activities | (3.39) | 0.22 | (9.67) | (0.98) | 0.18 | (4.13) | (0.94) |
| Net cash from investing activities | (18.29) | 0.18 | 9.93 | 0.02 | (0.89) | 0.96 | 0.46 |
| Net cash from financing activities | 43.84 | (0.42) | (0.18) | (0.07) | (0.13) | 3.09 | 0.75 |
| Net change in cash | 22.17 | (0.02) | 0.08 | (1.03) | (0.85) | (0.07) | 0.26 |
| Closing cash | 22.17 | 0.00 | 0.02 | 0.04 | 0.19 | 0.80 | 0.87 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | -44.0% | -57.7% | -12.6% | -18.3% | -59.0% | +112.7% | - |
| EBITDA growth | -256.3% | +95.3% | -540.0% | -158.1% | -131.8% | +575.6% | - |
| PBT growth | -45.6% | +93.5% | -430.8% | -209.4% | - | +9998.0% | +68.6% |
| Net income growth | -63.3% | +18.9% | +62.4% | -155.8% | -144.5% | +2262.5% | - |
| Revenue CAGR (3Y) | -40.8% | -32.9% | -33.6% | -10.7% | -0.3% | +38.8% | +8.0% |
| EBITDA CAGR (3Y) | +2.2% | -8.2% | - | +57.4% | -21.5% | - | -22.2% |
| Profitability & leverage | |||||||
| Net income margin | -80.3% | -29.8% | -203.5% | -33.5% | -10.7% | +28.5% | -1.0% |
| Return on capital employed | 0.0% | 0.0% | 0.0% | -12.5% | -3.9% | +16.8% | 0.0% |
| Return on net worth | 0.0% | 0.0% | 0.0% | -13.9% | -5.0% | +14.6% | 0.0% |
| Debt / equity | 0.02 | 0.36 | 0.13 | 0.05 | 0.01 | 0.06 | 0.14 |
| Long-term debt / equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest cover | -7.81 | -13.51 | -1.33 | -5.79 | -3.30 | 3.59 | -21.31 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.25 | 0.51 | 1.21 | 1.38 | 1.70 | 3.74 | 1.63 |
| Inventory turnover | 1.31 | 1.57 | 2.41 | 2.21 | 2.45 | 5.61 | 3.75 |
| Debtors turnover | 14.35 | 13.63 | 8.17 | 5.33 | 5.50 | 9.73 | 4.80 |
| EPS (βΉ) | (0.86) | (1.39) | (22.42) | (4.21) | (1.64) | 10.72 | (0.20) |
| Dividend per share (βΉ) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (βΉ) | 33.96 | 4.42 | 5.79 | 28.18 | 32.39 | 34.01 | 19.56 |
Timeline of Ador Multiproducts
3 dated milestones of Ador Multiproducts across 72 years, from founding to its latest funding, stage changes and deals.
- Founded Ador Multiproducts is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round.
Competitors of Ador Multiproducts
Ador Multiproducts has 3 listed competitors in our database, 1 of them funded. They include Primacy Industries, Influx Healthtech and Stella Indusstries.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| primacyind.com | 2005 | Mangaluru, India | $41.05M | 618 | Scented candles, air, personal care, and hygiene products are contract-manufactured. | |
| influxhealthtech.com | 2003 | Mumbai, India | 160 | Contract based manufacturer of healthcare products | ||
| stella-indusstries.com | 1983 | Gurugram, India | 91 | Produces high-quality personal care products, including aerosols and cosmetics. |
Detailed competitors of Ador Multiproducts
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Contract & Outsourced Manufacturing
3 companies that operate in the same segment as Ador Multiproducts (Contract & Outsourced Manufacturing) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Industrial components, mould bases, and storage solutions are manufactured globally. | 1986 | Coimbatore, Tamil Nadu, India | USD 28 M | USD 853.09 M | 3,060 | |
Single- and three-phase transformers are manufactured in Mumbai. | 1993 | Mumbai, Maharashtra, India | USD 114.37 M | 618 | ||
Apparel and clothing are manufactured and exported on contract. | 1979 | Bengaluru, Karnataka, India | USD 400 M | 40,280 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ador Multiproducts
Complete news archive for Ador Multiproducts
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ador Multiproducts
Ador Multiproducts was founded in 1948 and raised its 1st funding round 72 years after it was founded.
Ador Multiproducts is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Ador Multiproducts has 7 employees.
The primary company behind Ador Multiproducts, Thrive Future Habitats Limited, reported revenue of βΉ2.33 Cr for FY 2026, down 44% year on year.
Ador Multiproducts was founded in 1948 and operates in the personal care sector. Skin care items, hygiene products such as hand sanitizers, and both alcohol-based and herbal options are produced and supplied. Contract manufacturing services are provided from facilities located in Bengaluru and Pondicherry, with headquarters in Mumbai, India.
Ador Multiproducts's top competitors include Influx Healthtech, Stella Indusstries and Primacy Industries.
Ador Multiproducts offers Sublime Life, Cocomo, Anatomicals, Booth & Berkeley, and Santic.
Yes, Ador Multiproducts is publicly traded on BSE under the ticker symbol ADORMUL.
Ador Multiproducts operates through Thrive Future Habitats Limited.
The legal entities of Ador Multiproducts currently have 5 directors, including Sandeep Ahuja, Pinki Sharma, Arvinder Singh Pasricha and others.
